Effect of attention and interpretation therapy on sleep dysfunction and quality of life in perimenopausal syndrome patients
10.3760/cma.j.cn211501-20200805-03444
- VernacularTitle:关注阐释疗法对围绝经期综合征患者睡眠障碍及生命质量的影响
- Author:
Bin WU
1
;
Yajing FAN
;
Ying XUE
;
Xiaoyan CHEN
;
Ling HUANG
;
Lu LU
Author Information
1. 上海市第六人民医院妇产科 200233
- Keywords:
Attention and interpretation therapy;
Perimenopausal syndrome;
Sleep dysfunction;
Quality of life
- From:
Chinese Journal of Practical Nursing
2021;37(28):2202-2208
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effect of attention and interpretation therapy on sleep dysfunction and quality of life in perimenopausal syndrome patients.Methods:From August 2018 to January 2020, a total of 76 patients with perimenopausal syndrome were divided into experimental group (38 cases) and control group (38 cases) according to the random number table method. Two groups recieved routine therapy and nursing care, on the basis of this, the experimental group was given attention and interpretation therapy for 10 weeks. Before intervention and after 10 weeks of intervention, the effects were assessed by Pittsburgh Sleep Quality Index (PSQI) and Menopause-Specific Quality of Life (MENQOL), respectively.Results:There was no significant difference in the score of PSQI, MENQOL before intervention between the two groups ( P>0.05). After intervention, the sleep quality, sleep duration, sleep efficiency scores and total PSQI scores were 0.79±0.10, 1.48±0.23, 1.11±0.22, 9.70±0.59; in addition, the vasomotor symptoms, psychological symptoms, somatic symptoms and total MENQOL scores were 3.06±0.81, 2.06±0.81, 2.50±0.51, 2.63±0.39 in the experimental group, significanlty lower than those in the control group (1.03±0.22, 1.85±0.33, 1.25±0.28, 10.59±0.66, 3.69±0.95, 2.83±0.77, 2.92±0.94, 3.18±0.53), the differences were statistically significant ( t values were 2.306-6.021, P<0.05). Conclusions:Attention and interpretation therapy can effectively alliviate sleep dysfunction and improve quality of life of perimenopausal syndrome patients.
